phenyl acetate has been researched along with Right Ventricular Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calderone, A; Daneault, C; Dupuis, J; Fen Shi, Y; Gagnon, L; Grouix, B; Laurin, P; Nguyen, QT; Nsaibia, MJ; Ruiz, M; Sirois, MG; Tardif, JC | 1 |
| Airaksinen, KE; Bax, KE; Engblom, E; Kalliokoski, R; Knuuti, J; Koistinen, J; Naum, A; Nekolla, SG; Stolen, KQ; Sundell, J; Ylitalo, A | 1 |
1 trial(s) available for phenyl acetate and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Assessment of right ventricular oxidative metabolism by PET in patients with idiopathic dilated cardiomyopathy undergoing cardiac resynchronization therapy.
Topics: Acetates; Carbon; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Female; Heart Ventricles; Humans; Male; Middle Aged; Oxygen; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Ventricular Dysfunction, Right | 2004 |
1 other study(ies) available for phenyl acetate and Right Ventricular Dysfunction
| Article | Year |
|---|---|
PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
Topics: Acetates; Animals; Cells, Cultured; Disease Models, Animal; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; Heart Failure; Heart Ventricles; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Interleukin-6; Lung; Male; Phosphorylation; Pulmonary Fibrosis; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Transforming Growth Factor beta; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Remodeling | 2020 |